A panel of experts specializing in eye care speak with Mr. Dermott Ryan, a patient with Demodex blepharitis, to gain a better understanding of how the disease impacts patients. Mr. Ryan provides valuable insight and backs the efficacy of lotilaner ophthalmic solution 0.25%, the first FDA-approved treatment for Demodex blepharitis. ...
Demodex Blepharitis Roundtable Series
Advertisement
Eye care experts provide a physician-focused perspective on the current treatment paradigm for Demodex blepharitis.
A panel of experts discusses lotilaner ophthalmic solution 0.25%, the first FDA-approved treatment for Demodex blepharitis.
An ophthalmology panel explains the pros and cons of the current standard of care for treating Demodex blepharitis.
A panel of experts discusses how Demodex blepharitis presents and what treatment options are typically used.
A panel provides a breakdown on Demodex blepharitis, a prevalent ocular disease caused by an infestation of Demodex mites.
Advertisement
DocWire News delivers the latest medical industry news, giving health care professionals the curated content most relevant to their fields and practices.
Get the latest medical updates and insights straight to your inbox.
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.